Related references
Note: Only part of the references are listed.Immune checkpoint inhibitors as potential triggers for ANCA vasculitis
Faten Aqeel et al.
RMD OPEN (2022)
ANCA-associated pauci-immune necrotizing glomerulonephritis during the treatment with pembrolizumab
Meral Uner et al.
VIRCHOWS ARCHIV (2021)
A Systematic Review of Immune Checkpoint Inhibitor-Associated Glomerular Disease
Abhijat Kitchlu et al.
KIDNEY INTERNATIONAL REPORTS (2021)
Efficacy of Plasmapheresis in Nivolumab-Associated ANCA Glomerulonephritis: A Case Report and Pathophysiology Discussion
Reda Laamech et al.
CASE REPORTS IN NEPHROLOGY AND DIALYSIS (2021)
Renal Vasculitis and Pauci-immune Glomerulonephritis Associated With Immune Checkpoint innioitors
Alexander J. Gallan et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
T-lymphocyte in ANCA-associated vasculitis: what do we know? A pathophysiological and therapeutic approach
Laura Martinez Valenzuela et al.
CLINICAL KIDNEY JOURNAL (2019)
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
Omar Mamlouk et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Antineutrophil Cytoplasmic Antibody–Associated Rapid Progressive Glomerulonephritis after Pembrolizumab Treatment in Thymic Epithelial Tumor: A Case Report
Mi Hwa Heo et al.
Journal of Thoracic Oncology (2017)
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
Frank B. Cortazar et al.
KIDNEY INTERNATIONAL (2016)